Mira Pharmaceuticals MIRA
NASDAQ MIRA
$0.62 -0.01 (-1.49%)
At close: Oct 23, 2026 · 4:00 PM EDT

Mira Pharmaceuticals (MIRA) Accumulated Expenses (2022 - 2025)

Updated

Mira Pharmaceuticals (MIRA) reported Accumulated Expenses of $5,500 for the quarter ended Mar 31, 2025, down 98.2% from the prior quarter.

Analysis

Mira Pharmaceuticals (MIRA) Accumulated Expenses (2022 - 2025) Analysis & Trends

As of Dec 31, 2024, Mira Pharmaceuticals posted Accumulated Expenses of $300,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Mira Pharmaceuticals 14.58 Mn -5.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 5,500.00
Dec 31, 2024 300,000.00
Mar 31, 2024 14,472.00
Dec 31, 2023 14,472.00
Dec 31, 2022 34,987.00
API Access

Mira Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MIRA&period=max&api_key=YOUR_API_KEY